Tobacco Use in Opioid Agonist Treated Pregnant Women

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

September 30, 2009

Study Completion Date

June 30, 2010

Conditions
Nicotine Dependence
Interventions
BEHAVIORAL

tobacco abstinent contingent

Participants receive vouchers wiht monetary rewards for providing breath samples that show tobacco smoking abstinence

BEHAVIORAL

non-contingent

Participants receive vouchers regardless of tobacco use status

BEHAVIORAL

control

this group receives no vouchers

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Center for Addiction and Pregnancy, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT00497068 - Tobacco Use in Opioid Agonist Treated Pregnant Women | Biotech Hunter | Biotech Hunter